Healthcare provider profile · identity verified

David Schwartz, MD

Family Practice · WAUKON, IA · NPI 1528058062

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	289	66
Atorvastatin Calcium	Atorvastatin Calcium	255	78
Metoprolol Succinate	Metoprolol Succinate	215	56
Gabapentin	Gabapentin	210	34
Levothyroxine Sodium	Levothyroxine Sodium	194	38
Potassium Chloride	Potassium Chloride	185	43
Furosemide	Furosemide	177	40
Lisinopril	Lisinopril	174	44
Amlodipine Besylate	Amlodipine Besylate	159	44
Tamsulosin Hcl	Tamsulosin Hcl	153	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	138	38
Simvastatin	Simvastatin	135	30
Prednisone	Prednisone	131	69
Citalopram Hbr	Citalopram Hydrobromide	130	31
Lorazepam	Lorazepam	124	27
Eliquis	Apixaban	119	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	24
Pantoprazole Sodium	Pantoprazole Sodium	103	21
Metformin Hcl	Metformin Hcl	99	25
Losartan Potassium	Losartan Potassium	93	30
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	86	11
Famotidine	Famotidine	82	13
Metoprolol Tartrate	Metoprolol Tartrate	81	20
Spironolactone	Spironolactone	79	19
Warfarin Sodium	Warfarin Sodium	75	16
Tramadol Hcl	Tramadol Hcl	73	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	70	14
Rosuvastatin Calcium	Rosuvastatin Calcium	65	17
Torsemide	Torsemide	61	12
Clopidogrel	Clopidogrel Bisulfate	60	15
Glipizide	Glipizide	58	13
Allopurinol	Allopurinol	57	12
Clonazepam	Clonazepam	55	11
Mirtazapine	Mirtazapine	54	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	15
Hydrochlorothiazide	Hydrochlorothiazide	49	13
Finasteride	Finasteride	48	15
Metformin Hcl Er	Metformin Hcl	48	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	48	13
Carvedilol	Carvedilol	47	13
Fluticasone Propionate	Fluticasone Propionate	47	14
Jardiance	Empagliflozin	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Cefdinir	Cefdinir	45	42
Myrbetriq	Mirabegron	44	suppressed
Ozempic	Semaglutide	44	suppressed
Sertraline Hcl	Sertraline Hcl	44	17
Alprazolam	Alprazolam	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Diazepam	Diazepam	41	13
Atenolol	Atenolol	40	15
Digoxin	Digoxin	40	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	suppressed
Fentanyl	Fentanyl	38	suppressed
Levetiracetam	Levetiracetam	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Fluconazole	Fluconazole	37	11
Methotrexate	Methotrexate Sodium	37	suppressed
Creon	Lipase/Protease/Amylase	36	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Estradiol	Estradiol	35	16
Oxycodone Hcl	Oxycodone Hcl	35	12
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Trazodone Hcl	Trazodone Hcl	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	12
Albuterol Sulfate Hfa	Albuterol Sulfate	30	14
Dexamethasone	Dexamethasone	30	17
Oxybutynin Chloride	Oxybutynin Chloride	30	12
Diltiazem 24hr Er	Diltiazem Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Baclofen	Baclofen	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Meloxicam	Meloxicam	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Sucralfate	Sucralfate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	18
Doxycycline Monohydrate	Doxycycline Monohydrate	23	18
Entresto	Sacubitril/Valsartan	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	suppressed
Tresiba Flextouch U-200	Insulin Degludec	22	suppressed
Cephalexin	Cephalexin	20	12
Mounjaro	Tirzepatide	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Linzess	Linaclotide	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Methylprednisolone	Methylprednisolone	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	14
Pentoxifylline	Pentoxifylline	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Nitroglycerin	Nitroglycerin	14	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Disulfiram	Disulfiram	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Levofloxacin	Levofloxacin	13	12
Methocarbamol	Methocarbamol	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Topiramate	Topiramate	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valproic Acid	Valproic Acid	12	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error